-
Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion
Sep 9, 2025, 16:22 PM -
Modeling Treatment-Free Remission Outcomes for Asciminib in Newly Diagnosed Chronic Myeloid Leukemia: Assumptions, Methodology, and Projections
Sep 9, 2025, 16:22 PM -
Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis
Sep 9, 2025, 16:22 PM -
Evaluating EU-HTA PICO Exercise Outcomes: Duration of Response and Time to Response in Hepatocellular Carcinoma Using Randomization-Preserving Methods with IMbrave150 Data
Sep 9, 2025, 16:22 PM -
The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of a Real-World Comparator Cohort Using Multiple Qualifying Index Lines of Therapy (LOTs) in Third-Line or Later (3L+) Diffuse Large B-cell Lymphoma (DLBCL)
Sep 9, 2025, 16:22 PM -
Healthcare Costs in People With Type 2 Diabetes Remaining on or Escalating From Basal-Supported Oral Therapy: A 5-Year German Statutory Health Insurance Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Sep 9, 2025, 16:22 PM -
Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons
Sep 9, 2025, 16:22 PM -
Epidemiological Characteristics and Economic Burden of IgA Nephropathy—a Retrospective Study Using Multicenter Electronic Medical Records Data in China
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Generalizing the Lp(a) Dosing in Secondary Prevention in a Population of French Patients With Cardiovascular Disease
Sep 9, 2025, 16:22 PM -
Saving Money Improving Outcomes: A Two-Year Cost-Utility Analysis of Emergency Department Care Models for Managing Persons Presenting With a Musculoskeletal Disorder
Sep 9, 2025, 16:22 PM -
Quantification of Life-Cycle Value Using Early Modeling to Support RD and Strategy Decisions: A Case Study of a Polymeric Heart Valve
Sep 9, 2025, 16:22 PM -
CDF or CDFoe: How Has the Cancer Drugs Fund Impacted Access to Atezolizumab for Patients With Non-Small Cell Lung Cancer in the Adjuvant Setting?
Sep 9, 2025, 16:22 PM -
What Does the New ILAP Refresh Mean for Pharmaceutical Development and Patient Access in the UK?
Sep 9, 2025, 16:22 PM -
Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US
Sep 9, 2025, 16:22 PM -
Quality of Systematic Reviews With Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Sep 9, 2025, 16:22 PM -
Potential Nephrocalcinosis Risk Linked to Nusinersin: Insights from FAERS-Based Signal Detection and Molecular Docking
Sep 9, 2025, 16:22 PM -
Assessing Time Tradeoff Utilities in Health States of Organic Hypogonadotropic Hypogonadism: A Pilot Study in Brazil
Sep 9, 2025, 16:22 PM
